IL6 and neoplasm: The B1 receptor stimulation decreases melanoma cell migration and decreases tumor growth, proliferation, vascularization and immune cell infiltration, while increasing the expression of the pro-inflammatory and anti-tumor cytokines IFN-γ and IL-6.